header
Image from OpenLibrary

Impact of interferon alpha-2 alleles and anti interferon alpha-2 antibodies in HCV infected patients as predictive factors for response to interferon therapy / Ahmad Mohamed Rashad Mashaal ; Supervised Wahid Doss , Mohammed Saber , Moataz Hassan

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Ahmad Mohamed Rashad Mashaal , 2013Description: 122 P. : charts ; 25cmOther title:
  • مردود تحديد الأليلات و الأجسام المضادة للأنترفيرون الفا٢ فى مرضى فيروس "سى" كعوامل تنبوئية للأستجابة لعقار الأنترفيرون [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Tropical Medicine Summary: The world health organization has declared HCV as a global health problem, with approximately 3% of the world's population infected with HCV with considerable regional varlations. Prediction of treatment response in patients with chronic HCV infection is a cructal issue particularly with the current poor response rate, high cost and many side effects of therapy
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.33.Ph.D.2013.Ah.I (Browse shelf(Opens below)) Not for loan 01010110062711000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.33.Ph.D.2013.Ah.I (Browse shelf(Opens below)) 62711.CD Not for loan 01020110062711000

Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Tropical Medicine

The world health organization has declared HCV as a global health problem, with approximately 3% of the world's population infected with HCV with considerable regional varlations. Prediction of treatment response in patients with chronic HCV infection is a cructal issue particularly with the current poor response rate, high cost and many side effects of therapy

Issued also as CD

There are no comments on this title.

to post a comment.